Related Experiment Video
Updated: May 26, 2026
07:46
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
When Less Is More: Volume Considerations in the Treatment of Enterococcus faecalis Endocarditis
Sami El-Dalati1, William Harris2
1Division of Infectious Diseases, Department of Internal Medicine, University of Kentucky HealthCare, Lexington, Kentucky, USA.
Open Forum Infectious Diseases
|May 25, 2026
Summary
Current intravenous ampicillin and ceftriaxone treatments for Enterococcus faecalis endocarditis may cause fluid overload. Exploring push administration and oral therapy could reduce heart failure risks in these patients.
Area of Science:
- Infectious Diseases
- Cardiology
- Pharmacology
Background:
- The standard treatment for Enterococcus faecalis endocarditis involves a 6-week intravenous course of ampicillin and ceftriaxone.
- This regimen necessitates substantial fluid and salt administration, posing risks of hypervolemia and heart failure in susceptible patients.
- Recent intravenous fluid shortages prompted a shift towards push administration of medications, revealing potential for alternative delivery methods.
Purpose of the Study:
- To evaluate alternative administration strategies for ampicillin and ceftriaxone in treating Enterococcus faecalis endocarditis.
- To explore methods for reducing the incidence of hypervolemia and heart failure associated with current treatment protocols.
- To assess the feasibility and safety of push administration and partial oral antibiotic therapy.
Main Methods:
- Review of current treatment guidelines for Enterococcus faecalis endocarditis.
- Analysis of the impact of intravenous fluid administration on patient outcomes.
- Examination of the effects of push administration and partial oral therapy on medication delivery and patient safety.
Main Results:
- The standard intravenous regimen is linked to increased risks of hypervolemia and heart failure.
- Push administration of medications, including ampicillin and ceftriaxone, was implemented during fluid shortages without reported adverse effects.
- Partial oral antibiotic therapy presents a potential adjunct to reduce overall fluid and salt burden.
Conclusions:
- Alternative administration methods like push delivery and oral therapy may mitigate risks associated with Enterococcus faecalis endocarditis treatment.
- Reducing fluid and salt administration is crucial for improving outcomes in patients with E. faecalis endocarditis.
- Further research into evidence-based partial oral antibiotic strategies is warranted to optimize patient care.
Related Concept Videos
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:25Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
01:29Endocarditis IV: Nursing Management
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
01:25Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...